tiprankstipranks
Advertisement

DXIV - ETF AI Analysis

Compare

Top Page

DXIV

Dimensional International Vector Equity ETF (DXIV)

Rating:62Neutral
Price Target:
DXIV, the Dimensional International Vector Equity ETF, has a solid overall rating driven mainly by high-quality holdings like ASML, Novartis, and AstraZeneca, which benefit from strong financial performance, positive earnings calls, and clear growth strategies. Energy names such as TotalEnergies, Shell, and Suncor also support the fund with stable profitability and dividends, though some holdings like Orange and Deutsche Telekom face bearish or neutral technical trends and valuation concerns that modestly weigh on the rating. The main risk factor is the fund’s notable exposure to specific sectors like energy and healthcare, which could increase sensitivity to sector-specific downturns.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, which helps reduce the impact if any single market struggles.
Strong Performance So Far This Year
The ETF has delivered solid gains year-to-date and in recent months, showing positive momentum for investors.
Several Strong Top Holdings
Many of the largest positions, especially in energy, materials, and technology, have shown strong performance, supporting the fund’s overall returns.
Negative Factors
Higher Expense Ratio Than Some Broad ETFs
The fund’s fee is moderate but not among the very lowest, which slightly reduces net returns over time.
Exposure to Underperforming Holding
One of the top positions has shown weak performance, which can drag on the fund if that stock continues to struggle.
Meaningful Energy and Materials Exposure
Significant exposure to energy and materials companies can make the fund more sensitive to swings in commodity prices and global economic conditions.

DXIV vs. SPDR S&P 500 ETF (SPY)

DXIV Summary

Dimensional International Vector Equity ETF (DXIV) is an international stock fund that invests in companies outside the U.S., without tracking a specific index. It spreads money across many countries like Japan, the UK, and Germany, and across many sectors, including financials, industrials, and energy. Well-known holdings include ASML Holding and AstraZeneca. Someone might invest in DXIV to diversify beyond U.S. stocks and seek long-term growth from both developed and emerging markets. A key risk is that international stocks can be volatile and are affected by currency swings and global economic conditions, so the value can go up and down.
How much will it cost me?The Dimensional International Vector Equity ETF (DXIV) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on a refined selection of international stocks to enhance potential returns.
What would affect this ETF?DXIV's focus on developed markets outside the U.S. and its exposure to sectors like Industrials, Financials, and Consumer Cyclical could benefit from global economic growth and increased infrastructure spending. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance. The ETF's top holdings in energy and healthcare companies may also be influenced by fluctuating commodity prices and evolving healthcare policies.

DXIV Top 10 Holdings

DXIV’s story is less about one star stock and more about a deep international bench. Energy names like TotalEnergies and Suncor have been key engines, rising over the year even if they’ve hit a recent soft patch, while Shell has been a steadier contributor. ASML adds a dose of high-powered European tech momentum, and big pharma players such as Novartis and AstraZeneca provide a more defensive backbone. With holdings spread across Europe, Canada, and other developed markets outside the U.S., the fund avoids single-name risk and leans on broad, global diversification.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
TotalEnergies SE1.11%$1.62M€164.70B45.23%
78
Outperform
BHP Group Ltd0.80%$1.17MAU$285.03B66.90%
68
Neutral
ASML Holding0.73%$1.06M$559.08B112.92%
81
Outperform
Novartis0.70%$1.02M$263.90B28.02%
80
Outperform
Shell0.63%$913.05K$249.99B31.64%
78
Outperform
Suncor Energy0.61%$883.20K$76.21B80.54%
77
Outperform
ORANGE SA0.60%$881.80K€46.93B41.56%
65
Neutral
Roche Holding AG0.54%$791.69K$327.04B22.13%
73
Outperform
AstraZeneca0.54%$783.87K$292.69B32.74%
80
Outperform
Nestlé SA0.54%$782.38KCHF205.30B-1.29%
71
Outperform

DXIV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
69.43
Positive
100DMA
68.29
Positive
200DMA
64.27
Positive
Market Momentum
MACD
0.43
Positive
RSI
55.82
Neutral
STOCH
51.66
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DXIV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.57, equal to the 50-day MA of 69.43, and equal to the 200-day MA of 64.27, indicating a bullish trend. The MACD of 0.43 indicates Positive momentum. The RSI at 55.82 is Neutral, neither overbought nor oversold. The STOCH value of 51.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DXIV.

DXIV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$143.27M0.30%
62
Neutral
$997.51M0.50%
63
Neutral
$621.51M0.59%
60
Neutral
$438.43M0.65%
63
Neutral
$437.25M0.23%
65
Neutral
$150.29M0.83%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DXIV
Dimensional International Vector Equity ETF
70.81
17.81
33.60%
SEIE
SEI Select International Equity ETF
FYLD
Cambria Foreign Shareholder Yield ETF
TXUE
Thornburg International Equity ETF
AVSD
Avantis Responsible International Equity ETF
RFDI
First Trust Riverfront Dynamic Developed International ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement